维普期刊资源整合服务平台（V6.5）

235篇 您的检索式：作者名="WATKINS PB"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance显示文摘	Lau WC Gurbel PA Watkins PB	2004	Circulation2004，109，：	1
2	Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation : a new drug-drug interaction 显示文摘	Lau WC Waskell LA Watkins PB	2003	Circulation2003，107，：	1
3	Contribution of he- patic cytochrome P450 3A4 metabolic activity to the phe- nomenon of clopidogrel resistance显示文摘	Lau WC Gurbel PA Watkins PB	2004	Circulation2004，109，2：	1
4	Systemic inflammation after drug-eluting stent placement显示文摘	Gogo PB Schneider DJ Watkins MW	2005	J Thromb Thrombolysis2005，19，2：	1
5	Atorvastatin reducesthe ability of clopidogrel to inhibit platelet aggregation : a newdrug-drug interaction 显示文摘	Lau WC Waskell LA Watkins PB	2003	Circulation2003，107，1：	1
6	Contribution of hepatic cytochrome p450 3A4 metabolic activity to the phenomenon of clopidogrel resistance显示文摘	Lau WC Gurbel PA Watkins PB	2004	Circulation2004，109，2：	1
7	The barrier function of CYP3A4 and P-glycoprotein in the small bowel显示文摘	WATKINS PB	1997	Adv Drug Deliv Rev1997，27，23：	1
8	Systemic inflammation after drug-eluting stent placement 显示文摘	Gogo PB Jr Schneider D J Watkins MW	2005	J Thromb Thmmbolysis2005，19，2：	1
9	Case definition and pheno-type standardization in drug - induced liver injury 显示文摘	Aithal GP> Watkins PB Andrade RJ *	2011	Clin PharmacolTher2011，89，6：	1
10	Contribution of he- patic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance 显示文摘	Lau WC Gurbel PA Watkins PB	2004	Circulation2004，109，2：	1
11	Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation:a new drug-drug interaction显示文摘	LAU WC WASKELL LA WATKINS PB	2003	Circulation2003，107，1：	1
12	Systemic inflammation after drug-eluting stent placement显示文摘	Gogo PB Jr Schneider DJ Watkins MW	2005	J Thromb Thrombolysis2005，19，2：	1
13	Contribution of hepatic cy- tochrome P450 3A4 metabolic activity to the phenomenon of clopi- dog relresistance 显示文摘	Lau WC Gurbel PA Watkins PB	2004	Circulation2004，109，2：	1
14	Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance 显示文摘	Lau WC Gurbel PA Watkins PB	2004	Circulation2004，109，：	1
15	Contribution of hepatic cytochrome P 450 3A4 metabolic activity to the phenomenon of clopidogrel resistance显示文摘	Lau WC Gurbel PA Watkins PB	2004	Circulation2004，109，2：	1
16	Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation : a new drug-drug interaction 显示文摘	Lau WC Waskell LA Watkins PB	2003	Circulation2003，107，1：	1
17	Drug safety sciences and the bottleneck in drug development显示文摘	Watkins PB	2011	Clin Pharmacol Ther2011，89，6：	1
18	Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance 显示文摘	Lau WC Gurbel PA Watkins PB	2004	Circulation2004，109，2：	1
19	Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct显示文摘	Fontana RJ Watkins PB Bonkovsky HL	2009	Drug Saf2009，32，1：	1
20	Case definition andphenotype standardization in drug-induced liver injury 显示文摘	Aithal GP Watkins PB Andrade RJ	2011	ClinPharmacol Ther2011，89，6：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示